Advancing leptomeningeal metastases treatment in EGFR-mutated non-small cell lung cancer: lessons from the BLOSSOM trial

Martina Bortolot, Jarno W.J. Huijs, Dieta Brandsma, Annette Compter, Robin M.J.M. van Geel, Lizza E.L. Hendriks*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalTranslational Lung Cancer Research
Volume14
Issue number1
DOIs
Publication statusPublished - 24 Jan 2025

Keywords

  • BLOSSOM trial
  • epidermal growth factor receptor (EGFR)
  • leptomeningeal metastases (LM)
  • Non-small cell lung cancer (NSCLC)
  • osimertinib

Cite this